Annals On Call - Why Do Patients Develop Anemia With Chronic Inflammation?
Authors: Robert M. Centor, Mounica Vallurupalli
Journal: Annals of Internal Medicine (2020)

Web Exclusives21 July 2020Annals On Call - Why Do Patients Develop Anemia With Chronic Inflammation?FREERobert M. Centor, MD and Mounica Vallurupalli, MDRobert M. Centor, MDHuntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Search for more papers by this author and Mounica Vallurupalli, MDBrigham and Women's Hospital, Boston, Massachusetts (M.V.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/A19-0034 CME/MOC SectionsAboutVisual Abstract ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In this episode of Annals On Call, Dr. Centor discusses inflammation-associated anemia and its response to interluekin-1β inhibition with canakinumab in CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) with trial investigator Dr. Mounica Vallurupalli.Annals articles discussed include...Effects of Interleukin-1β Inhibition on Incident Anemia: Exploratory Analyses From a Randomized Trial: www.acpjournals.org/doi/10.7326/M19-2945About Annals On CallAnnals On Call focuses on a clinically influential article published in Annals of Internal Medicine. Dr. Robert Centor shares his own perspective on the material and interviews topic area experts to discuss, debate, and share diverse insights about patient care and health care delivery.For more information on Annals On Call and for more episodes, visit go.annals.org/OnCall. Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationAffiliations: Huntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Brigham and Women's Hospital, Boston, Massachusetts (M.V.)Disclosures: Dr. Centor has disclosed the following: Consultancy: DynaMed, MDCalc, Medscape, National Kidney Foundation, The Curbsiders. Employment: U.S. Department of Veterans Affairs. Dr. Vallurupalli has disclosed no conflicts of interest.Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Eliseo Guallar, MD, MPH, DrPH, Deputy Editor, Statistics, reports that he has no financial relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose. Previousarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoEffects of Interleukin-1β Inhibition on Incident Anemia Mounica Vallurupalli , Jean G. MacFadyen , Robert J. Glynn , Tom Thuren , Peter Libby , Nancy Berliner , and Paul M Ridker Metrics 21 July 2020Volume 173, Issue 2Page: OC1KeywordsAnemiaConflicts of interestDiagnostic techniquesDisclosureHealth careInflammationKidneysPatientsRandomized trialsThrombosis ePublished: 21 July 2020 Issue Published: 21 July 2020 Copyright & PermissionsCopyright © 2020 by American College of Physicians. All Rights Reserved.Loading ...